Merck reported that the USFDA had approved enflosina (clesrovimab-cfor) to prevent respiratory syncytial virus (RSV)-induced lower respiratory tract illness in newborns and babies beginning their first RSV season.
Bharat Biotech International Limited (BBIL) announces a strategic partnership with GSK plc to advance the development and distribution of the Shigella vaccine candidate, altSonflex1-2-3. Shigellosis, a serious bacterial...
The Indian Pharmaceutical Alliance (IPA) represents major domestic drug companies has expressed concern over a recent directive from the government which bans medical representatives from visiting
 (1).png "Apisolex Excipient by Lubrizol Backs Phase I Drug Success")
A promising drug candidate using Lubrizol Life Science Health's new polymer excipient Apisolex has begun Phase I clinical trials. This marks a big step forward for the technology that boosts solubility.
Brenntag, the leading distributor of chemicals and additives worldwide, announced that it has acquired mcePharma in the Czech Republic. Brenntag's capabilities throughout the whole pharmaceutical
Biocon Foundation, the CSR arm of Biocon Group, has launched BioWISE – Women in STEM Empowered – a pioneering initiative to support women science students from underrepresented communities in Karnataka. In collaboration with The Bengaluru Scien...
Leading diagnostic chains in India are scaling up operations amid a sharp rise in Covid-19 cases, driven by new variants such as JN.1, NB.1.8.1, and LF.7. According to diagnostic labs, RT-PCR tests have risen by 70 percent as people become more aware
.jpeg "Parexel Secures CDSCO Approval Under G.S.R 581(E) Guidelines")
Parexel, a top-ranked international clinical research organisation (CRO), has formally registered with India's Central Drugs Standard Control Organisation (CDSCO), in line with the newly imposed G.S.R 581(E) regulation.
.jpeg "OneSource's Flagship Bangalore Plant Remains USFDA Compliance")
neSource Specialty Pharma Limited (BSE: 544292, NSE: ONESOURCE), a multi-modality specialty pharma pure-play CDMO, announced that its flagship facility in Bangalore, India.
.jpeg "Cadila Steps Into Cardiac Care with New Beta-Blocker Therapy")
Ahmedabad-based company, Cadila Pharmaceuticals, has entered the space of beta-blocker therapy by introducing Biscado (Bisoprolol), a notable milestone in the improvement of its portfolio in cardiac care.
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")